SCHEMBL7775362

SCHEMBL7775362

CC(C)Oc1ccccc1N1CCN(CC(N)c2nc3ccc(F)cc3s2)CC1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 10/20 0.44
ADRA1D P25100 9/20 0.44
ADRA1B P35368 4/20 0.44
DRD4 P21917 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7775341 0.99 ADRA1A (0.44) ADRA1AADRA1DADRA1BDRD4
SCHEMBL7856186 0.91 DRD3 (0.49)
SCHEMBL7773447 0.89 HTR7 (0.45) ADRA1AADRA1DDRD4
Bromide SCHEMBL7848004 0.88 HTR7 (0.44) ADRA1AADRA1DDRD4
SCHEMBL7775357 0.87 CSNK1D (0.37)
SCHEMBL27571993 0.87 NPC1 (0.38)
Bromide SCHEMBL7857243 0.86 CSNK1D (0.36)
Fumaric Acid SCHEMBL7855787 0.84 DRD3 (0.49) DRD4
SCHEMBL27565726 0.82 NPC1 (0.44)
Bromide SCHEMBL7773488 0.81 NPC1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed